参考文献 References
[1] Association B. H., Prevention B. D., Association T., et al. 基层心血管病综合管理实践指南2020 %J 中国医学前沿杂志(电子版).2020;12(08): 1-73.
[2] 《中国心血管健康与疾病报告》2021（冠心病部分内容）%J 心肺血管病杂志.2023;42(11): 1093-6.
[3] Xuemei Z., Yifei W., Wei L., et al. Cumulative Remnant Cholesterol as a causal risk factor for Ischemic Heart Disease: A Prospective Cohort Study. %J Current problems in cardiology.2023;49(2): 102215-.
[4] Lim G. B. Inclusion of remnant cholesterol improves risk prediction for ischaemic heart disease. Nature reviews Cardiology.2022;19(8): 504.
[5] Zhao Y., Zhuang Z., Li Y., et al. Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity. Nat Commun. 2024;15(1): 2451.
[6] Chait A. Multifactorial chylomicronemia syndrome. Current Opinion in Endocrinology, Diabetes & Obesity. 2024; 31(2): 78-83.
[7] 卜晓丹, 卜晓翠. 不同分型冠心病患者血清指标的变化水平研究.菏泽医学专科学校学报.2023;35(03): 5-8+32.
[8] Zhang Y., Gao Y., Zhou G., et al. Centerline-supervision multi-task learning network for coronary angiography segmentation.Biomed Signal Process Control.2023;82 (104510.
[9] Feng R., Lin Q., Wei D., et al. Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review.Medicine. 2023;102(41):
[10] Shao H., Huang Y., Xu D., et al. A Systematic Review and Meta-Analysis on the Efficacy of Puerarin Injection as Adjunctive Therapy for Unstable Angina Pectoris. Frontiers in cardiovascular medicine.2022;9 (2297-055X (Print)):
[11] 白潇萱, 贾海波. 坏死性凋亡在动脉粥样硬化及相关疾病中的作用.心血管康复医学杂志.2023;32(02): 134-8.
[12] Kopin L., Lowenstein C. J. Dyslipidemia. Annals of Internal Medicine.2017;167(11):
[13] 任妹, 夏洪娇, 刘剑荣, et al. 冠心病发生及脂代谢紊乱与血浆致动脉硬化指数的相关性研究.当代医学.2021; 27(13): 8-10.
[14] Erica F., Sarah J., Renee S., et al. Biological Variability of Small Dense LDL, HDL3, and Triglyceride-Rich Lipoprotein Cholesterol %J American Journal of Clinical Pathology. 2021;156(Supplement1): S4-S.
[15] 冯丹, 李娜, 侯东燕. 血清残粒脂蛋白胆固醇浓度与急性心肌梗死相关性分析.首都医科大学学报.2023;44(05): 872-6.
[16] Kunimura A., Miura K. Is remnant cholesterol a new therapeutic target for preventing hypertension? Hypertension Research. 2024;47(5): 1227-8.
[17] Wang K., Wang R., Yang J., et al. Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment. Frontiers in cardiovascular medicine.2022;9(913869.
[18] Filtz A., Parihar S., Greenberg G. S., et al. New approaches to triglyceride reduction: Is there any hope left?American Journal of Preventive Cardiology.2024; 18(2666-6677 (Electronic)):
[19] Nordestgaard B. G., Freiberg J. J., Varbo A. Extreme nonfasting remnant cholesterol versus extreme low-density lipoprotein cholesterol as contributors of cardiovascular disease and all-cause mortality in 90,000 individuals from the general population. Atherosclerosis. 2015;241(1):
[20] 巨名飞, 刘超, 于健, et al. 急性心肌梗死患者残余胆固醇及血常规参数变化的意义.国际老年医学杂志.2020; 41(06): 364-6.
[21] Guo D. C., Gao J. W., Wang X., et al. Remnant cholesterol and risk of incident hypertension: a population-based prospective cohort study. LID - 10.1038/s41440-023-01558-7
[22] 孙楷文, 王虹艳. 残粒胆固醇在动脉粥样硬化相关疾病中的研究进展.中华高血压杂志.2023;31(05): 419-24.
[23] Xiong C.-C., Gao F., Zhang J.-H., et al. Investigating the impact of remnant cholesterol on new-onset stroke across diverse inflammation levels: Insights from the China Health and Retirement Longitudinal Study (CHARLS). International Journal of Cardiology. 2024;405(1874-1754 (Electronic)):
[24] Qian S., You S., Sun Y., et al. Remnant Cholesterol and Common Carotid Artery Intima-Media Thickness in Patients With Ischemic Stroke. Circulation Cardiovascular imaging.2021;14(4): e010953.
[25] Cheng Q., Li Z., Wang X., et al. Relation Between New York Heart Association Functional Class and Remnant Cholesterol, and Non-high Density Lipoprotein Cholesterol in Coronary Heart Disease Patients With Type 2 Diabetes Mellitus.Angiology.2022;74(1): 39-46.
[26] Wu X., Qiu W., He H., et al. Associations of the triglyceride-glucose index and remnant cholesterol with coronary artery disease: a retrospective study. %J Lipids in health and disease.2024;23(1): 45-.
[27] J. H., P. B., B. A., et al. Interstitial postprandial hyperlipidemia and remnant lipoproteins in type 2 diabetes mellitus %J Atherosclerosis.2021;331(e7-e.
[28] Vergès B. Dyslipidemia in Type 1 Diabetes: AMaskedDanger %J Trends in Endocrinology & Metabolism.2020;31(6): 422-34.
[29] 王钰哲, 孔璐璐, 葛丹, et al. 残余胆固醇与糖尿病视网膜病变相关性的研究.中国糖尿病杂志.2023;31(10): 741-4.